bioecon Member area
Technology · Synbio & enabling tech / Foundries & design

CAD software for synthetic biology

Computer-aided design software that lets a synthetic biologist draft a genetic construct, simulate its behavior and generate an assembly protocol before a single base pair is synthesized — the digital design layer upstream of both the wet-lab gene-synthesis foundries and the strain-engineering CROs already covered on this site, borrowing the electronic-design-automation model from semiconductor chip design.

Bioinformatics & Computation Multidisciplinary Omics Maturity 4/9 Risk: medium Digital & robotics Research tools & R&D services US · CN · EU Science: why it works → verified 2026-08-11 · 4 Sources (0 independent)

1 · What it gives

CAD software for synthetic biology applies the electronic-design-automation model from semiconductor chip design to genetic engineering: a biologist drafts a genetic construct in software, simulates how the design will behave, and generates an assembly protocol — all before committing to physical DNA synthesis. One platform’s patented machine-learning engine closes design-build-test-learn cycles ten times faster than random screening; another traces its core technology to Cello, a hybrid genetic-engineering and CAD platform originally built to program logic circuits directly into living cells. This is the digital design layer that sits upstream of both the commercial gene-synthesis foundries and the strain-engineering contract research organizations already covered on this site — the software drafts and simulates the construct, the foundry physically synthesizes it, and the CRO engineers the resulting strain, three distinct stages with three distinct vendor sets.

Key directions of CAD software for synthetic biology:

  1. BioCAD/CAM platforms (BioCAD/CAM Platform): integrated design, simulation and assembly-protocol-generation software spanning the full design-build cycle for a genetic construct.
  2. Design-build-test-learn automation (DBTL Automation): machine-learning and AI-agent tooling that closes the iterative cycle of designing, building, testing and refining a biological system faster than traditional screening.
  3. Custom bespoke software development (Bespoke Synbio Software): software studios that embed with biotech companies to build internal design tools and workflow software rather than selling a one-size-fits-all product.
  4. Genetic part and circuit simulation (Genetic Part Simulation): simulation engines that predict how a genetic circuit or part will behave in a target cell type before physical construction.

Sectoral value chain#

[genetic construct drafting] ──> [behavior simulation] ──> [assembly protocol generation] ──> [DBTL iteration]
                                                                        │
                                                          (physical synthesis handoff)
                                                                        │
                                                                        ▼
[optimized genetic design] <─── [experimental data feedback] <──┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Construct draftingdesigning a genetic sequence or circuit in softwareIn: design intent, genetic-part library. Out: draft construct design.
Behavior simulationpredicting how the design will function in a target cellIn: draft construct, host-organism model. Out: simulated behavior prediction.
Assembly protocol generationgenerating the physical lab protocol to build the constructIn: finalized design. Out: assembly protocol (e.g. Gibson, Golden Gate).
Physical synthesis handoffprotocol transferred to a gene-synthesis foundry or in-house labIn: assembly protocol. Out: synthesized physical construct.
Experimental data feedbacktest results fed back into the design platformIn: lab/assay results. Out: structured data for the next design cycle.
DBTL iterationrefining the design based on experimental dataIn: experimental feedback. Out: optimized next-generation design.

Cross-cutting technologies:

  • BioCAD/CAM platform (BioCAD/CAM Platform): integrated software spanning genetic design, simulation and protocol generation.
  • DBTL automation (Design-Build-Test-Learn Automation): ML/AI tooling accelerating iterative biological design cycles.
  • Genetic part simulation (Genetic Part Simulation): predictive modeling of genetic circuit behavior before physical construction.

2 · What it replaces 3 · matched by industry

D3E–Agricultural spraying drones instead of knapsack and manned aerial spraying
Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying
EAC
D2E–Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays
Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale …
MACRO
D3E2Genomic selection in dairy cattle breeding instead of progeny testing
Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs)
BREED

3 · How to implement 6 steps

  1. 1
    Design intent capture
    The biologist specifies the desired function of the genetic construct — what behavior or output the design should produce in the target host cell.
  2. 2
    Construct draftingTesting & analytics
    The software assembles a candidate genetic sequence or circuit from a library of characterized genetic parts, matching the specified design intent.
    Who can do this step matched automatically
    FastBio Brazil
    “Com forte networking e com parcerias estabelecidas junto as principais Contract Research Organizations (CROs), a FastBio disponibiliza um portfolio de serviços biológicos …”
    Turion Labs Singapore
    “Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
  3. 3
    Behavior simulation
    A simulation engine predicts how the drafted construct will behave in the target cell type, flagging likely failure modes before any physical synthesis is committed to.
  4. 4
    Protocol generation
    The platform generates the physical lab assembly protocol — a Gibson assembly, Golden Gate cloning or similar method — needed to build the finalized construct.
  5. 5
    Physical synthesis handoffSynthesis & conversion
    The generated protocol and construct design are handed off to a gene-synthesis foundry or in-house lab for physical construction.
    Who can do this step matched automatically
    100 tons industrial scale
    “typical catalysts).”
    ✓ ISO 9001 600 tons pilot scale
    “Protein expression is limited by multiple bottlenecks, such as transcription efficiency, translation efficiency, metabolic constraints, protein folding, and hydrolysis.”
    163,050 tonnes
    “Uniquely equipped with the credentials for the R&D, design, and production of both high-efficiency dust filtration materials and SCR denitration catalysts, as well as for the …”
  6. 6
    Data feedback and DBTL iteration
    Experimental results from the physically built and tested construct are fed back into the design platform, closing the design-build-test-learn loop and informing the next design iteration.

4 · Who delivers

Matched suppliers (matched automatically)

Liying Biotech 粒影生物ChinaProduceractive
Caladan BioUnited StatesProduceractive
Tsingke BiotechnologyChinaProduceractive
Dassault SystemesFranceProduceractive
BIONETSpainEquipmentactive
PUEVIT GmbHGermanyEquipmentactive
Shengquan GroupChinaProduceractive
Paris Biofoundry (France)FranceResearch / RTOactive
Bluepha 蓝晶微生物ChinaProduceractive
Bota Bio 恩和生物ChinaProduceractive
Shanghai/SIAT SynBio foundries (China)ChinaProduceractive

In the services and supply catalogue 1 · paid service

Process modelling & simulation

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
TeselaGen🇺🇸 USABioCAD/CAM platform, Synthetic Evolution®Patented ML engine closes DBTL cycles 10x faster than random screening; AI design agentsCommercial
Lattice Automation🇺🇸 USACustom synbio software developmentEmbeds with biotech teams to build bespoke internal design toolsCommercial
Synthace🇬🇧 UKDigital Experiment Platform (Antha®)Cloud-based DOE automation; validated by AstraZeneca, GSK, Charles RiverCommercial
Asimov🇺🇸 USACAD platform built on the Cello genetic-circuit systemCloud-based design/simulation across cell types; DARPA-funded AI design engine researchCommercial

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

The US hosts the category’s most established and most heavily funded platforms, spanning an AI-native design-automation company, a bespoke software studio, and a CAD platform that originated as an academic logic-circuit-programming tool.

AI-accelerated DBTL platforms, bespoke embedded software studios, academic-to-commercial CAD lineage#

  • TeselaGen (founded 2013): offers a BioCAD/CAM platform built around Synthetic Evolution®, a patented machine-learning engine the company states closes design-build-test-learn cycles ten times faster than random screening, alongside AI agents for library design and sequence optimization.
  • Lattice Automation: a life-sciences software development studio that embeds with biotech teams to build custom internal design tools and workflow software rather than selling a single standardized product.
  • Asimov’s CAD platform: co-founded in 2017 by the MIT professor behind Cello, a hybrid genetic-engineering/CAD system originally built to program logic-circuit behaviors into living cells, now offered as cloud-based software to design, simulate and optimize genetic systems across cell types.

European Union

The UK hosts a design-of-experiments software pioneer that pivoted from wet-lab synthetic biology into pure software, now validated by major pharmaceutical companies.

academic spinout to pure-software pivot, design-of-experiments automation, pharma-validated platform#

  • Synthace (London, founded 2011): a University College London spinout that operated as a synthetic biology company before pivoting fully to software in 2017; its cloud-based Digital Experiment Platform automates design-of-experiments for complex biological processes, validated by AstraZeneca, GSK and Charles River.
  • EU AI Act context: as CAD platforms increasingly embed machine-learning design-automation features, general-purpose AI model obligations under the EU AI Act are an emerging compliance consideration for European synbio-software vendors specifically.
  • Recognition track record: Synthace was named a World Economic Forum Technology Pioneer in 2016 and a Gartner Cool Vendor in Life Sciences in 2018, external validation markers for a category where commercial traction can otherwise be hard to verify independently.

China

No confirmed Chinese commercial CAD-for-synthetic-biology vendor was found; Chinese activity in this space is concentrated in academic and student competition projects rather than standalone commercial software products.

academic and iGEM-competition tool development, no confirmed commercial vendor, broader synbio manufacturing capacity elsewhere#

  • iGEM student competition tools: Chinese university teams have built award-winning genetic-circuit-design software (gene-circuit visual analytics, computer-aided synbio design tools) through the international iGEM synthetic-biology competition, demonstrating strong academic capability without a confirmed spinout into standalone commercial software.
  • No confirmed specialist producer: searches for a mainland commercial BioCAD vendor returned only academic and open-source tools — left qualitative pending a real commercial candidate.
  • Broader synbio capacity context: China’s substantial gene-synthesis and strain-engineering manufacturing capacity, covered elsewhere on this site, has not yet produced a confirmed standalone commercial design-software export comparable to the US platforms.

6 · Money: tenders & grants

7 · Tech stack & innovations

The category borrows its core methodology from semiconductor electronic design automation, adapted to the added complexity of biological systems that don’t behave with silicon’s predictability.

  1. Machine-learning-accelerated DBTL cycling (ML-Driven Design Iteration):
    • Patented ML engines learn from each round of experimental results to propose the next design iteration more efficiently than exhaustive or random screening, the core mechanism behind claimed order-of-magnitude speedups in design cycles.
    • AI agents increasingly handle specific sub-tasks within the cycle — library design, sequence optimization — rather than the platform being a single monolithic tool.
  2. Genetic circuit and part simulation (Predictive Behavior Modeling):
    • Simulation engines predict how a genetic circuit will behave in a specific host cell type before physical construction, the capability that originated in academic logic-circuit-programming research before being commercialized.
    • Simulation accuracy depends on the quality and breadth of the underlying genetic-part behavior library, making part-library curation as important as the simulation algorithm itself.
  3. Cloud-based design-of-experiments automation (DOE Platform Architecture):
    • Cloud platforms let a biologist design multivariate experiments, simulate them digitally, execute them on connected lab hardware and receive structured, AI-ready data — a no-code workflow bridging digital design and physical lab execution.
    • This architecture is what lets a platform originally built by synthetic biologists for their own use pivot into a standalone software product sold to other biotech companies.

Sources 4 · 0 independent · 4 producer sites

Producers' own sites 4

  1. Teselagen producer checked 2026-08-11 · link not kept
  2. Lattice automation producer checked 2026-08-11 · link not kept
  3. Synthace producer checked 2026-08-11 · link not kept
  4. Asimov producer checked 2026-08-11 · link not kept